Mika, a 35-year-old man, quickly obtained a prescription for the weight-loss drug Ozempic through a brief online consultation, raising concerns about the telehealth practices involved in prescribing such medication.
The article discusses Mika's experience using telehealth services to obtain a prescription for Ozempic, a weight-loss medication. After struggling with weight management, Mika had a five-minute chat consultation with a physician at the Medilux clinic, which allowed him to get the medication within hours. He noted the efficiency of the process, stating he received the prescription in his hand and went straight to the pharmacy.
Medilux's CEO, Rishat Jarullin, indicates that such telehealth consultations are standard practice in the field for evaluating patients seeking obesity medication and reviewing their medical history. While this practice streamlines access to treatment, it raises questions about the thoroughness of patient assessments conducted via chat and the responsibilities of healthcare providers in ensuring patient safety and appropriate use of medication.
Clinical metabolism professor Kirsi Pietiläinen criticized the practice of prescribing obesity medications through chat platforms, highlighting the potential risks associated with insufficient patient evaluations. The article calls for a balanced discussion regarding the accessibility of weight-loss medications through modern telehealth services versus the need for comprehensive medical evaluations before prescribing such treatments.
